Related Experiment Video

Updated: Jun 8, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment

Patricia J Eifel

    Nature Reviews. Clinical Oncology
    |September 30, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
    09:48

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

    Published on: September 12, 2019

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.

    Brachytherapy·2023

    Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.

    Gynecologic oncology·2023

    Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring.

    Cancer cell·2023

    Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer.

    Clinical and translational radiation oncology·2023

    Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.

    BMC cancer·2022

    Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment.

    Practical radiation oncology·2022

    Exploring the landscape of targetable alterations in patients with glioblastoma.

    Nature reviews. Clinical oncology·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

    Nature reviews. Clinical oncology·2026

    Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90Y Radioembolization with Immunotherapy in HCC.

    Radiology·2026

    Performance of Photon-counting CT for Assessing Pretreatment Breast Cancer: Comparison with Mammography, MRI, and 18F-FDG PET/CT.

    Radiology·2026

    Photic Cycle Shorter Than or Equal to Endogenous tau Postpones Diet-Induced Obesity in Mice and Shows a Robust Aftereffect.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

    Sono-Triggered In Situ Vaccine via a Chlorin-Based Small Molecule Sensitizer for Systemic Cancer Therapy.

    Angewandte Chemie (International ed. in English)·2026

    Cryoballoon ablation versus antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: the multicenter randomized CEPAF trial.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

    Ovarian puncture alters genes but not follicle growth in cyclophosphamide mice model.

    Reproduction & fertility·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us